Printer Friendly
The Free Library
19,588,385 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Analysis of The Worldwide Markets For Biogenerics In US$ Million.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41038) has announced the addition of Biogenerics - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Biogenerics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2007 through 2013. The report profiles 42 companies including many key and niche players worldwide.

Content Titles Include:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II.

1. Market Overview

2. Trends and Issues

3. Drug Approval Process in US and Europe

4. Product Overview

5. Recent Industry Activity

6. Focus on Select Players

7. Global Market Perspective

II. COMPETITION

Some Companies Mentioned include:

Anhui Anke Bio Tech (China)

Barr Laboratories, Inc (USA)

Bharat Biotech International Limited (India)

Biocon India Limited (India)

Clinigene (India)

Biogenerics GmbH (Germany)

Biogenerics Pharma (USA)

BiogeneriX AG (Germany)

Biopartners (Switzerland)

Cangene Corporation (Canada)

CIGB CIGB Commission Internationale des Grands Barrages (French: International Commission on Large Dams)  (Cuba)

Cipla Ltd (India)

Crucell NV (The Netherlands)

Dr Reddys Laboratories Ltd (India)

Dragon Pharmaceuticals, Inc (USA)

Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States.  (USA)

Ferring Pharmaceuticals Ferring Pharmaceuticals is a pharmaceutical company that specializes on the development and marketing of peptides for the use in human medicine. It was founded by Frederik Paulsen in Malmö, Sweden in 1950 initially as the Nordiska Hormon Laboratoriet, renamed Ferring  (USA)

Gene Medicine Japan, Inc (Japan)

GeneMedix PLC (UK)

Inno Biologics Sdn Bhd SDN BHD Sendirian Berhad (Malay equivalent to incorporated)  (Malaysia)

Insight Biopharmaceuticals Ltd (Israel)

Intas Pharmaceuticals Ltd (India)

LG Life Sciences (Korea)

Mayne Pharma PLC (UK)

Merck KGAA This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article.  (Germany)

Microbix Biosystems, Inc (Canada)

Migenix, Inc (Canada)

Momenta Pharmaceuticals, Inc (USA)

Neose Technologies, Inc (USA)

Novartis AG Novartis AG

Swiss pharmaceutical company. It was formed through the 1996 merger of two Swiss firms: Ciba (see Ciba-Geigy) and Sandoz, a chemical company with interests in pharmaceuticals, nutrition, and agriculture.
 (Switzerland)

Sandoz International GmbH (Germany)

Sandoz, Inc (USA)

Novo Nordisk Wikipedia is not the place for advertisement or self-advertising. Novo Nordisk (, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest  A/S (Denmark)

Pfizer, Inc (USA)

Pliva DD (Croatia)

Ranbaxy Laboratories Ltd (India)

Savient Pharmaceuticals, Inc (USA)

Shantha Biotechnics Limited (India)

Shenyang Sunshine Pharmaceutical Co, Ltd (China)

Stada Arzneimittel AG (Germany)

Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in  Ltd (Israel)

Teva Pharmaceuticals (USA)

Sicor, Inc (USA)

Vaccinex, Inc (USA)

Wockhardt Ltd (India)

Zenotech Laboratories Ltd (India)

Zydus Cadila (India)

For more information visit http://www.researchandmarkets.com/reports/c41038
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 23, 2006
Words:305
Previous Article:The German Pharmaceutical Industry is under Severe Price Constraints and Methods Imposed by the Government Limit Pharmaceutical Expenditure.
Next Article:Segments Analyzed Are Injectables, Solid Dosage Forms, and Liquid Dosage Forms for Pharmaceutical Contract Manufacturing 2000 - 2009.



Related Articles
Research and Markets: Biogenerics: Drivers and Resistors of Market Development.
Research and Markets: Strategies for Biogeneric Success.
Cost Cutting in Healthcare Expanding Markets for Generic and Biogeneric Products.
Research and Markets - Biogenerics: Challenges and Promise.
The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth Drivers and Leading Players.
Biogenerics 2005: An Emerging Global Market?
Delay in U.S. Regulatory Approval Significantly Lowers Forecast for BioGenerics Market to $2.3 billion.
Biogenerics Could Now Enter the EU Market in a Matter of Months, and the US by 2009 with a Global Market of $20 Billion Predicted.
Omnitrope Breaks Biogeneric Barriers Says visiongain Report.
In The Spring of 2006, Two Companies Made History by Producing the First Two Approved Biogenerics in the European Union - Toward a Biogenerics...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles